Report cover image

Global Mononucleosis Diagnostic Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18750271

Description

Global Mononucleosis Diagnostic Databank Market Report


The Mononucleosis Diagnostic market was valued at $2,621.6 Million in 2022, and is projected to reach $3,098.2 Million by 2031 growing at a CAGR of 1.91% from 2023 to 2031. Complete Blood Count Test segment is expected to be the highest contributor to this market, with $1,138.6 Million in 2022, and is anticipated to reach $1,210.1 Million by 2031, registering a CAGR of 0.71%. Epstein Barr Virus segment is anticipated to reach $744.9 Million by 2031 with the highest CAGR of 2.81%. Complete Blood Count Test and Epstein Barr Virus segments collectively expected to account for about 65.6% share of the Mononucleosis Diagnostic market in 2022, with the former constituting around 43.4% share. Epstein Barr Virus and Antibody Test segments are expected to witness significant growth rates at a CAGR of 2.81% and 2.75% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 41.0% in the overall Mononucleosis Diagnostic market in 2022, and is anticipated to reach 44.3% by 2031.

Table of Contents

100 Pages
1. Global Mononucleosis Diagnostic Market, By Test Type
1.1. Overview
1.2. Epstein Barr Virus
1.2.1 Epstein Barr Virus Market, By Region
1.2.1.1 North America Epstein Barr Virus Market, By Country
1.2.1.2 Europe Epstein Barr Virus Market, By Country
1.2.1.3 Asia-Pacific Epstein Barr Virus Market, By Country
1.2.1.4 Rest of World Epstein Barr Virus Market, By Country
1.3. Antibody Test
1.3.1 Antibody Test Market, By Region
1.3.1.1 North America Antibody Test Market, By Country
1.3.1.2 Europe Antibody Test Market, By Country
1.3.1.3 Asia-Pacific Antibody Test Market, By Country
1.3.1.4 Rest of World Antibody Test Market, By Country
1.4. Monospot Test
1.4.1 Monospot Test Market, By Region
1.4.1.1 North America Monospot Test Market, By Country
1.4.1.2 Europe Monospot Test Market, By Country
1.4.1.3 Asia-Pacific Monospot Test Market, By Country
1.4.1.4 Rest of World Monospot Test Market, By Country
1.5. Complete Blood Count Test
1.5.1 Complete Blood Count Test Market, By Region
1.5.1.1 North America Complete Blood Count Test Market, By Country
1.5.1.2 Europe Complete Blood Count Test Market, By Country
1.5.1.3 Asia-Pacific Complete Blood Count Test Market, By Country
1.5.1.4 Rest of World Complete Blood Count Test Market, By Country
2. Global Mononucleosis Diagnostic Market, By End User
2.1. Overview
2.2. Hospitals
2.2.1 Hospitals Market, By Region
2.2.1.1 North America Hospitals Market, By Country
2.2.1.2 Europe Hospitals Market, By Country
2.2.1.3 Asia-Pacific Hospitals Market, By Country
2.2.1.4 Rest of World Hospitals Market, By Country
2.3. Laboratories
2.3.1 Laboratories Market, By Region
2.3.1.1 North America Laboratories Market, By Country
2.3.1.2 Europe Laboratories Market, By Country
2.3.1.3 Asia-Pacific Laboratories Market, By Country
2.3.1.4 Rest of World Laboratories Market, By Country
2.4. Other End Users
2.4.1 Other End Users Market, By Region
2.4.1.1 North America Other End Users Market, By Country
2.4.1.2 Europe Other End Users Market, By Country
2.4.1.3 Asia-Pacific Other End Users Market, By Country
2.4.1.4 Rest of World Other End Users Market, By Country
3. Global Mononucleosis Diagnostic Market, By Region
3.1. Overview
3.2. North America
3.2.1 North America Mononucleosis Diagnostic Market, By Test Type
3.2.2 North America Mononucleosis Diagnostic Market, By End User
3.2.3 North America Mononucleosis Diagnostic Market, By Country
3.2.3.1 U.S.
3.2.3.1.1 U.S. Mononucleosis Diagnostic Market, By Test Type
3.2.3.1.2 U.S. Mononucleosis Diagnostic Market, By End User
3.2.3.2 Canada
3.2.3.2.1 Canada Mononucleosis Diagnostic Market, By Test Type
3.2.3.2.2 Canada Mononucleosis Diagnostic Market, By End User
3.3. Europe
3.3.1 Europe Mononucleosis Diagnostic Market, By Test Type
3.3.2 Europe Mononucleosis Diagnostic Market, By End User
3.3.3 Europe Mononucleosis Diagnostic Market, By Country
3.3.3.1 Germany
3.3.3.1.1 Germany Mononucleosis Diagnostic Market, By Test Type
3.3.3.1.2 Germany Mononucleosis Diagnostic Market, By End User
3.3.3.2 U.K.
3.3.3.2.1 U.K. Mononucleosis Diagnostic Market, By Test Type
3.3.3.2.2 U.K. Mononucleosis Diagnostic Market, By End User
3.3.3.3 France
3.3.3.3.1 France Mononucleosis Diagnostic Market, By Test Type
3.3.3.3.2 France Mononucleosis Diagnostic Market, By End User
3.3.3.4 Italy
3.3.3.4.1 Italy Mononucleosis Diagnostic Market, By Test Type
3.3.3.4.2 Italy Mononucleosis Diagnostic Market, By End User
3.3.3.5 Spain
3.3.3.5.1 Spain Mononucleosis Diagnostic Market, By Test Type
3.3.3.5.2 Spain Mononucleosis Diagnostic Market, By End User
3.3.3.6 Rest of Europe
3.3.3.6.1 Rest of Europe Mononucleosis Diagnostic Market, By Test Type
3.3.3.6.2 Rest of Europe Mononucleosis Diagnostic Market, By End User
3.4. Asia-Pacific
3.4.1 Asia-Pacific Mononucleosis Diagnostic Market, By Test Type
3.4.2 Asia-Pacific Mononucleosis Diagnostic Market, By End User
3.4.3 Asia-Pacific Mononucleosis Diagnostic Market, By Country
3.4.3.1 China
3.4.3.1.1 China Mononucleosis Diagnostic Market, By Test Type
3.4.3.1.2 China Mononucleosis Diagnostic Market, By End User
3.4.3.2 Japan
3.4.3.2.1 Japan Mononucleosis Diagnostic Market, By Test Type
3.4.3.2.2 Japan Mononucleosis Diagnostic Market, By End User
3.4.3.3 South Korea
3.4.3.3.1 South Korea Mononucleosis Diagnostic Market, By Test Type
3.4.3.3.2 South Korea Mononucleosis Diagnostic Market, By End User
3.4.3.4 India
3.4.3.4.1 India Mononucleosis Diagnostic Market, By Test Type
3.4.3.4.2 India Mononucleosis Diagnostic Market, By End User
3.4.3.5 Singapore
3.4.3.5.1 Singapore Mononucleosis Diagnostic Market, By Test Type
3.4.3.5.2 Singapore Mononucleosis Diagnostic Market, By End User
3.4.3.6 Rest of Asia
3.4.3.6.1 Rest of Asia Mononucleosis Diagnostic Market, By Test Type
3.4.3.6.2 Rest of Asia Mononucleosis Diagnostic Market, By End User
3.5. Rest of World
3.5.1 Rest of World Mononucleosis Diagnostic Market, By Test Type
3.5.2 Rest of World Mononucleosis Diagnostic Market, By End User
3.5.3 Rest of World Mononucleosis Diagnostic Market, By Country
3.5.3.1 Brazil
3.5.3.1.1 Brazil Mononucleosis Diagnostic Market, By Test Type
3.5.3.1.2 Brazil Mononucleosis Diagnostic Market, By End User
3.5.3.2 Mexico
3.5.3.2.1 Mexico Mononucleosis Diagnostic Market, By Test Type
3.5.3.2.2 Mexico Mononucleosis Diagnostic Market, By End User
3.5.3.3 South Africa
3.5.3.3.1 South Africa Mononucleosis Diagnostic Market, By Test Type
3.5.3.3.2 South Africa Mononucleosis Diagnostic Market, By End User
3.5.3.4 Australia
3.5.3.4.1 Australia Mononucleosis Diagnostic Market, By Test Type
3.5.3.4.2 Australia Mononucleosis Diagnostic Market, By End User
3.5.3.5 ROW Countries
3.5.3.5.1 ROW Countries Mononucleosis Diagnostic Market, By Test Type
3.5.3.5.2 ROW Countries Mononucleosis Diagnostic Market, By End User
ROW Countries Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD LIST OF TABLES
TABLE 1. Global Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 2. Epstein Barr Virus Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America Epstein Barr Virus Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe Epstein Barr Virus Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific Epstein Barr Virus Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World Epstein Barr Virus Market Value, By Country, 2022-2031, Million USD
TABLE 7. Antibody Test Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America Antibody Test Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe Antibody Test Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific Antibody Test Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World Antibody Test Market Value, By Country, 2022-2031, Million USD
TABLE 12. Monospot Test Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America Monospot Test Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe Monospot Test Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific Monospot Test Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World Monospot Test Market Value, By Country, 2022-2031, Million USD
TABLE 17. Complete Blood Count Test Market Value, By Region, 2022-2031, Million USD
TABLE 18. North America Complete Blood Count Test Market Value, By Country, 2022-2031, Million USD
TABLE 19. Europe Complete Blood Count Test Market Value, By Country, 2022-2031, Million USD
TABLE 20. Asia-Pacific Complete Blood Count Test Market Value, By Country, 2022-2031, Million USD
TABLE 21. Rest of World Complete Blood Count Test Market Value, By Country, 2022-2031, Million USD
TABLE 22. Global Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 23. Hospitals Market Value, By Region, 2022-2031, Million USD
TABLE 24. North America Hospitals Market Value, By Country, 2022-2031, Million USD
TABLE 25. Europe Hospitals Market Value, By Country, 2022-2031, Million USD
TABLE 26. Asia-Pacific Hospitals Market Value, By Country, 2022-2031, Million USD
TABLE 27. Rest of World Hospitals Market Value, By Country, 2022-2031, Million USD
TABLE 28. Laboratories Market Value, By Region, 2022-2031, Million USD
TABLE 29. North America Laboratories Market Value, By Country, 2022-2031, Million USD
TABLE 30. Europe Laboratories Market Value, By Country, 2022-2031, Million USD
TABLE 31. Asia-Pacific Laboratories Market Value, By Country, 2022-2031, Million USD
TABLE 32. Rest of World Laboratories Market Value, By Country, 2022-2031, Million USD
TABLE 33. Other End Users Market Value, By Region, 2022-2031, Million USD
TABLE 34. North America Other End Users Market Value, By Country, 2022-2031, Million USD
TABLE 35. Europe Other End Users Market Value, By Country, 2022-2031, Million USD
TABLE 36. Asia-Pacific Other End Users Market Value, By Country, 2022-2031, Million USD
TABLE 37. Rest of World Other End Users Market Value, By Country, 2022-2031, Million USD
TABLE 38. Global Mononucleosis Diagnostic Market Value, By Region, 2022-2031, Million USD
TABLE 39. North America Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 40. North America Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 41. North America Mononucleosis Diagnostic Market Value, By Country, 2022-2031, Million USD
TABLE 42. U.S. Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 43. U.S. Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 44. Canada Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 45. Canada Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 46. Europe Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 47. Europe Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 48. Europe Mononucleosis Diagnostic Market Value, By Country, 2022-2031, Million USD
TABLE 49. Germany Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 50. Germany Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 51. U.K. Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 52. U.K. Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 53. France Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 54. France Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 55. Italy Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 56. Italy Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 57. Spain Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 58. Spain Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 59. Rest of Europe Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 60. Rest of Europe Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 61. Asia-Pacific Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 62. Asia-Pacific Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 63. Asia-Pacific Mononucleosis Diagnostic Market Value, By Country, 2022-2031, Million USD
TABLE 64. China Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 65. China Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 66. Japan Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 67. Japan Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 68. South Korea Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 69. South Korea Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 70. India Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 71. India Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 72. Singapore Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 73. Singapore Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 74. Rest of Asia Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 75. Rest of Asia Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 76. Rest of World Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 77. Rest of World Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 78. Rest of World Mononucleosis Diagnostic Market Value, By Country, 2022-2031, Million USD
TABLE 79. Brazil Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 80. Brazil Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 81. Mexico Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 82. Mexico Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 83. South Africa Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 84. South Africa Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 85. Australia Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 86. Australia Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
TABLE 87. ROW Countries Mononucleosis Diagnostic Market Value, By Test Type, 2022-2031, Million USD
TABLE 88. ROW Countries Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD
ROW Countries Mononucleosis Diagnostic Market Value, By End User, 2022-2031, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us